An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC-Reference-Cited by-同舟云学术

An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC

Published:2009-10-23 Issue:2 Volume:9 Page:141-150
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Goldberg Yael,Porat Rinnat M.,Kedar Inbal,Shochat Chen,Galinsky Daliah,Hamburger Tamar,Hubert Ayala,Strul Hana,Kariiv Revital,Ben-Avi Liat,Savion Moran,Pikarsky Eli,Abeliovich Dvorah,Bercovich Dani,Lerer Israela,Peretz Tamar

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

http://link.springer.com/content/pdf/10.1007/s10689-009-9298-9.pdf

Reference21 articles.

1. Abeliovich D, Kaduri L, Lerer I, Weinberg N et al (1997) The founder mutations 185delAG and 5382insc in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi woman. Am J Hum Genet 60:505–514

2. Banjerjee SK, Maldisi WF, Weston AP et al (1995) Microwave-based DNA extraction from paraffin-embedded tissue for PCR amplification. BioTechniques 18:768–773

3. Chan TL, Wai Chan Y, Ho JW et al (2004) MSH2 c. 1452–1455de1AATG is a founder mutation and an important cause of Hereditary Nonpolyposis Colorectal Cancer in the southern Chinese population. Am J Hum Genet 74:1035–1042

4. Chen S et al (2006) Prediction of germline mutations and cancer risk in the lynch syndrome. JAMA 296:1479–1487

5. Foulkes W, Thiffault I, Gruber SB et al (2002) The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71(6):1395–1412

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family;Molecular Genetics & Genomic Medicine;2023-01-24

2. An isolated childhood myeloid sarcoma with germline MSH6 mutation—a case report;Translational Pediatrics;2021-08

3. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications;Breast Cancer Research and Treatment;2021-06-04

4. Germline Variants and Phenotypic Spectrum in a Canadian Cohort of Individuals with Diffuse Gastric Cancer;Current Oncology;2020-05-01

5. Paediatric systemic lupus erythematosus as a manifestation of constitutional mismatch repair deficiency;Journal of Medical Genetics;2019-09-09